

On June 17, 1999, the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC) recommended an all-IPV schedule for routine childhood polio vaccination in the United States. As of January 1, 2000, all children should receive four doses of IPV at ages 2 months, 4 months, 6-18 months, and 4-6 years.
OPV should be used only for the following special circumstances:
This recommendation changes the one from 1997 when ACIP recommended a sequential schedule of inactivated poliovirus vaccine (IPV) followed by OPV to decrease the risk for vaccine-associated paralytic polio (VAPP) while maintaining the benefits of OPV. The change to an all IPV schedule is intended to eliminate the 4 to 5 cases of OPV-VAPP that occur in the US each year (Grabenstein, 1999). ACIP reaffirms its support for the global polio eradication initiative and use of OPV as the vaccine of choice to eradicate polio from the remaining countries where polio is endemic.
Because this change will increase the number of injections for immunization of children, nurses and other health professionals need to make every effort to decrease injection pain (Reis and others, 1998).
Grabenstein JD: IPV shift approved, Booster Shots: A Quarterly Supplement of ImmunoFacts, August 1999, p. 2.
Recommendations of the Advisory Committee on Immunization Practices: Revised Recommendations for Routine Poliomyelitis Vaccination, MMWR 48(27):590, July 16, 1999.
Reis EC and others: Taking the Sting Out of Shots: Control of Vaccination-Associated Pain and Adverse Reactions, Pediatric Annals 27(6):375-386, 1998.
A Cooling Spray (Fluori-Methane) Reduces Immunization Injection Pain
Guidelines for Atraumatic Skin/Vessel Punctures
Keeping Current on Vaccine Recommendations
See Chapter 10 in Essentials of Pediatric Nursing, 5th edition.
See Chapter 12 in Nursing Care of Infants and Children, 6th edition.
March 15, 2002